Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SEDentary Lifestyle, Mortality and Major Adverse Clinical Outcomes in Chronic KIDney Disease. A Prospective Multicenter Follow-up Protocol With a Nested Randomized Controlled Trial of Physical Education Benefits - The SEDKID Study

NCT06935786 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06935786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SEDentary Lifestyle, Mortality and Major Adverse Clinical Outcomes in Chronic KIDney Disease. A Prospective Multicenter Follow-up Protocol With a Nested Randomized Controlled Trial of Physical Education Benefits - The SEDKID Study
Lead sponsor
Turku University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
February 21, 2025
Completion date
December 31, 2031
Enrollment
400 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, chronic kidney disease, frailty